RecruitingEarly Phase IEN originalGlioma (brain cancer)

Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

This early phase I trial tests the safety, best dose, and effectiveness of SONALA-001 or 5-ALA HCL in combination with magnetic resonance imaging-guided focused ultrasound (MRgFUS), also called sonodynamic therapy, in treating patients with glioblastoma that is growing, spreading, or getting worse (progressive) or that has come back after a period of improvement (recurrent). Sonodynamic therapy is a non-invasive combination therapy that uses low-intensity ultrasound, such as MRgFUS, to activate a drug, such as SONALA-001 or 5-ALA HCL, to kill tumor cells. SONALA-001 or 5-ALA HCL binds to the tumor and may help the sonodynamic therapy target the tumor. MRgFUS is an image-guided, non-invasive technique that uses high energy ultrasound from the Exablate 4000 Type 2.0 device to kill tumors without damaging surrounding healthy tissue. Giving sonodynamic therapy using SONALA-001 or 5-ALA HCL with MRgFUS may be safe, tolerable, and/or effective in treating patients with progressive or recurrent glioblastoma.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Wiek co najmniej 18 lat
  • Rozpoznanie nawracającego lub postępującego glejaka mózgu, który nie kwalifikuje się do operacji
  • Poprzednia terapia napromienianiem
  • Przewidywana długość życia co najmniej 12 tygodni
  • Zdolność do powrotu do placówki do kontroli medycznych
  • Prawidłowe wyniki badań krwi (hemoglobina, płytki krwi, funkcja nerek i wątroby)
  • Ujemny test ciąży (jeśli dotyczy)
  • Pisemna świadoma zgoda na udział w badaniu

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
August 25, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (1)

Mayo Clinic in Rochester

Rochester, United States

Trial contact

Clinical Trials Referral Office

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/26/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.